(Q43892365)

English

Inhibition of androgen receptor functions by gelsolin FxxFF peptide delivered by transfection, cell-penetrating peptides, and lentiviral infection

scientific article published in February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Inhibition of androgen receptor functions by gelsolin FxxFF peptide delivered by transfection, cell-penetrating peptides, and lentiviral infection (English)

1 reference

Europe PubMed Central

27 November 2017

author name string

Dennis J van de Wijngaart

1

1 reference

Europe PubMed Central

27 November 2017

Hendrikus J Dubbink

2

1 reference

Europe PubMed Central

27 November 2017

Michel Molier

3

1 reference

Europe PubMed Central

27 November 2017

Carola de Vos

4

1 reference

Europe PubMed Central

27 November 2017

Guido Jenster

5

1 reference

Europe PubMed Central

27 November 2017

Jan Trapman

6

1 reference

Europe PubMed Central

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2011

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

71

1 reference

Europe PubMed Central

27 November 2017

241-253

1 reference

Europe PubMed Central

27 November 2017

3

1 reference

Europe PubMed Central

27 November 2017

The development of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Androgen receptors in endocrine-therapy-resistant human prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Androgen receptor as a target in androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Drug insight: role of the androgen receptor in the development and progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The androgen axis in recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Nuclear receptor structure: implications for function

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Differential requirement of SWI/SNF for androgen receptor activity

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Formation of the androgen receptor transcription complex

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Recognition and accommodation at the androgen receptor coactivator binding interface

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Structure and specificity of nuclear receptor-coactivator interactions

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Compartmentalization of androgen receptor protein-protein interactions in living cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The Use of Phage Display Technique for the Isolation of Androgen Receptor Interacting Peptides with (F/W)XXL(F/W) and FXXLY New Signature Motifs

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Identification of two transcription activation units in the N-terminal domain of the human androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The human androgen receptor: domain structure, genomic organization and regulation of expression.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Steroid receptor induction of gene transcription: a two-step model

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The FXXLF motif mediates androgen receptor-specific interactions with coregulators

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Peptides as protein binding site mimetics.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Peptidic modulators of protein-protein interactions: progress and challenges in computational design

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Inhibiting the p53-MDM2 interaction: an important target for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Targeting protein-protein interactions: lessons from p53/MDM2.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Definition of the molecular basis for estrogen receptor-related receptor-alpha-cofactor interactions

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Delivery of bioactive molecules into the cell: the Trojan horse approach

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

In vivo protein transduction: delivery of a biologically active protein into the mouse

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Recent advances in the use of cell-penetrating peptides for medical and biological applications

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

The androgen receptor in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Perturbation of Estrogen Receptor α Localization with Synthetic Nona-Arginine LXXLL-Peptide Coactivator Binding Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21238

21 January 2018

Identifiers

10.1002/PROS.21238

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43892365&oldid=2104194524"